Use your antibodies-online credentials, if available.
抗Human CYP1B1 抗体:
抗Mouse (Murine) CYP1B1 抗体:
抗Rat (Rattus) CYP1B1 抗体:
Cow (Bovine) Polyclonal CYP1B1 Primary Antibody for WB - ABIN2784612
Wang, Hawkins, Miller: Aryl hydrocarbon receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011
Show all 2 Pubmed References
Human Polyclonal CYP1B1 Primary Antibody for IHC (p), WB - ABIN4301719
Meireles, Esteves, Hirata, Peri, Devarajan, Slifker, Mosier, Peng, Vadhanam, Hurst, Neves, Reis, Gairola, Gupta, Clapper: Early changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue. in Cancer prevention research (Philadelphia, Pa.) 2010
Show all 2 Pubmed References
Human Polyclonal CYP1B1 Primary Antibody for IHC, IHC (p) - ABIN4301717
Rodrigues, De Kock, Branson, Vinken, Meganathan, Chaudhari, Sachinidis, Govaere, Roskams, De Boe, Vanhaecke, Rogiers: Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals. in Stem cells and development 2013
CYP1B1 single nucleotide polymorphisms association with lung cancer susceptibility in Polish smokers.
Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants
An increased breast cancer risk, independent of other breast cancer risk factors, was observed among carriers of CYP1B1 G119T genotype.
CYP1B1 mRNA expression in the preputial tissues from patients with hypospadias and phimosis
the CYP1B1 status in tissues from 76 patients diagnosed with non-small cell lung cancer, was investigated.
High CYP1B1 expression is associated with prostate cancer.
Data provide evidence that CYP1B1 plays a critical role in polycyclic aromatic hydrocarbon-mediated DNA damage.
genetic association studies in population of postmenopausal Mexican-Mestizo women: Data suggest SNPs in CYP1A1 (rs1799814, rs1048943; but not rs1056836 in CYP1B1) are associated with postmenopausal osteoporosis in the population studied; SNPs in CYP1A1 are associated with low bone mineral density in lumbar spine and femur neck. (CYP1A1 = aryl hydrocarbon hydroxylase CYP1A1; CYP1B1 = aryl hydrocarbon hydroxylase CYP1B1)
Juvenile onset open angle glaucoma and adult onset POAG form a spectrum of phenotypes. we analyzed the common variants in MYOC and CYP1B1 that were shared among all the three phenotypes .An interesting finding was that, while, many CYP1B1 variants were found in all three types of glaucoma, there was no reported MYOC variant, that was common to all the three primary glaucomas.
The frequency of p.E229K and p.R368H mutations of the CYP1B1 gene is low even among sporadic JOAG patients.
This pilot study revealed a significant association of the CYP1B1 Asn453Ser genotypes with the plasma levels of HDL-cholesterol and of apolipoprotein A1 in postmenopausal women and less unequivocal findings in premenopausal women.
We present an uncommon mutation and clinical description of CYP1B1 gene analysis demonstrated homozygosity for a 1-bp deletion in exon 2 (c.830delT).
In summary, these data expand the mutational and phenotypic spectra of CYP1B1 to include two novel alleles and additional developmental ocular phenotypes. The contribution of CYP1B1 to primary open angle glaucoma (POAG) is less clear, but loss-of-function variants in CYP1B1, especially c.1064_1076del, p.(Arg355Hisfs*69), may be associated with an increased risk for POAG.
In summary, a KLE cell-based model has been characterized to be suitable for identifying CYP1B1-targeted anticancer prodrugs and should be further developed and employed for screening chemical libraries.
AHR, CYP1A1, CYP1A2, or CYP1B1 variants associated with head-and-neck squamous cell carcinoma risk in smokers.
Our study identified nine different CYP1B1 mutations in 73.3% of the primary congenital glaucoma patients.
Our larger cohort suggests a tendency for girls with bi-allelic CYP1B1 mutations to have a more severe congenital phenotype as opposed to later-onset disease.
Increased expression of CYP1B1 is associated with ovarian/peritoneal endometriotic lesions.
CYP1B1 Leu432Val is associated with increased lung cancer susceptibility among Caucasians, and there is an interaction between CYP1B1 Leu432Val polymorphism and smoking, and Asn453- Ser and Ala119Ser may be not associated with lung cancer risk.
In this study, we identified 12 CYP1B1 mutations, 5 of which were novel. The frequency of CYP1B1 mutations in this cohort was comparable with other populations
Hepc decreases in Cyp1b1-/- and gestational vitamin A deficiency mice resulted in stellate activation and lipogenesis suppression.
Utilizing a mouse model, null for Cyp1b1 and expressing human CYP1B1, the study tested the hypothesis that hCYP1B1 is important for dibenzo[def,p]chrysene (DBC) transplacental carcinogenesis. hCYP1B1 genotype did not impact lung tumor multiplicity, but tended to enhance incidence compared to Cyp1b1 wild-type mice (P = 0.07).
CYP1B1 contributed to the development of Ang II-induced abdominal aortic aneurysm and associated pathogenic events in mice, likely by enhancing oxidative stress and associated signaling events
Miroestrol suppressed beta-naphthoflavone increases in CYP1B1.
Findings provide evidence that CYP1B1 is directly involved in the development of cardiac hypertrophy.
Cyp1b1 affects external control of mouse hepatocytes, fatty acid homeostasis and signaling involving HNF4alpha and PPARalpha.
hypertension, and associated pathogenesis in ApoE(-/-)/Cyp1b1(+/+) mice on an atherogenic diet are most likely dependent on CYP1B1-generated oxidative stress and increased plasma lipid levels independent of blood pressure and absorption of lipids.
Follicle stimulating hormone functions via p38 MAPK-induced dephosphorylation at Ser(727) of STAT1 to downregulate Cyp1b1 expression and maintain the estradiol levels in mouse dominant follicles.
Cyp1b1 contributes to angiotensin II induced hypertension and its pathogenesis in male mice.
Suggest that Cyp1b1 plays a critical role in female mice in protecting against renal dysfunction and end-organ damage associated with ANG II-induced hypertension.
Data indicaate that adduct formation in cytochrome P450 Cyp1b1 knockout mice was significantly reduced compared to wild-type mice receiving dibenzo[def,p]chrysene (DBC).
Cyp1b1 deletion substantially alters the expression of genes associated with fatty acid homeostasis
Data indicate that hepatic stearoyl-CoA desaturase 1 (SCD1) expression was decreased in cytochrome P450 1B1 (CYP1B1)-null mice.
Using inhibitors of p38 and MSKs, as well as mouse embryonic cells derived from p38alpha-deficient and MSK1/2 double knockout mice, we show here that TNF-alpha potentiates CYP1B1 upregulation via the p38/MSK1 kinase cascade
a direct role for mitochondrial CYP1B1 in PAH-mediated oxidative and chemical damage to mitochondria.
Cyp1B1 expression in vascular cells plays an important role in the regulation of the cellular reductive state, thrombospondin (TSP)2 expression, and NF-kappaB activation.
Metabolic activity of CYP1B1 contributes to oxidative homeostasis and ultrastructural organization and function of trabecular meshwork tissue through modulation of Postn expression.
In the present study we show that [a] NQO1 protein locates to cytosol, ER and mitochondria.
important role for Cyp1B1 expression in the regulation of pericyte proliferation, migration, and survival through modulation of the intracellular oxidative state and NF-kappaB expression and/or activity
Dexamethasone in combination with methylisobutylxanthine (DM) induces Cyp1b1 and a 6.7 kb mouse Cyp1b1 promoter-luciferase reporter in each cell type prior to adipogenesis. An 18 base sequence (at -6.11 kb) (PaxE) which was essential for this reporter stimulation in 3T3-L1 cells bound the transcription factor Pax6.
CYP1B1 knockdown studies show CYP1B1 is not a significant factor in causing synergistic toxicity of PAHs, nor, in contrast to CYP1A, in providing protection
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma\; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid.
aryl hydrocarbon hydroxylase
, cytochrome P450 1B1
, cytochrome P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile)
, flavoprotein-linked monooxygenase
, microsomal monooxygenase
, xenobiotic monooxygenase
, benz[a]anthracene inducible
, cytochrome P450, 1b1, benz[a]anthracene inducible
, cytochrome P450CMEF
, cytochrome P450EF
, cytochrome P450, subfamily 1B, polypeptide 1
, cytochrome P450RAP
, cytochrome P4501B
, cytochrome P450, family 1, subfamily B, polypeptide 1